A prospective study to compare the diagnostic accuracy of 99mTc-CNDG SPECT/CT and contrast-enhanced CT in staging of non-small cell lung cancer
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05953-6 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Qinfen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, Hainan, People's Republic of China. q…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Staging, Tomography, X-Ray Computed. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanya Medical and Health Technology Innovation Project.
Abstract (Originalsprache)
OBJECTIVE: To explore the value of 99mTc-isonitrile deoxyglucosamine (CNDG) SPECT/CT in the staging and resectability diagnosis of non-small cell lung cancer (NSCLC) compared with contrast-enhanced CT (CECT). METHODS: This research was approved by the hospital ethics review committee. Sixty-three patients with NSCLC received 99mTc-CNDG SPECT/CT, CECT and initial TNM staging before treatment. Thirty-three patients who underwent radical surgery underwent postoperative pathological TNM staging as the reference standard. Another thirty patients underwent radiochemotherapy; among them, the reference standard of 7 patients of N staging and 5 patients of M staging was based on biopsy pathology, and the diagnosis of the remaining lesions was confirmed by at least one different image or clinical imaging follow-up for more than 3 months. The McNemar test and receiver operating characteristic (ROC) curve analysis were used to compare the diagnostic accuracy of staging and resectability of 99mTc-CNDG SPECT/CT and CECT in NSCLC, respectively. RESULTS: For all patients and surgical patients, the accuracies of 99mTc-CNDG SPECT/CT in diagnosing the T stage and N stage were higher than those of CECT (all patients: 90.5%, 88.9% vs. 79.4%, 60.3%; surgical patients: 81.8%, 78.8% vs. 60.6%, 51.5%), and the differences were statistically significant (all patients: T stage, P = 0.016; N stage, P = 0.000; surgical patients: T stage, P = 0.016; N stage, P = 0.004). For all patients, the accuracy of 99mTc-CNDG SPECT/CT in diagnosing the M stage was higher than that of CECT (96.8% vs. 90.5%), but the difference was not statistically significant (P = 0.289). ROC curve analysis showed that the accuracy of 99mTc-CNDG SPECT/CT in diagnosing the potential resectability of NSCLC was significantly better than that of CECT (P = 0.046). CONCLUSION: This preliminary clinical study shows that 99mTc-CNDG SPECT/CT is of great value for accurate clinical staging of NSCLC compared with CECT and can significantly improve the accuracy of resectability diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, Hainan, People's Republic of China. qinfenwangcn@sina.cn.
- Department of Cardiothoracic Surgery, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, Hainan, People's Republic of China.
- Department of Oncology, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, Hainan, People's Republic of China.
- Department of Radiology, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, Hainan, People's Republic of China.
- Department of Nuclear Medicine, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, Hainan, People's Republic of China.
Förderung
- Sanya Medical and Health Technology Innovation Project
Zitieren
APA
Wang, Q., Deng, Z., Lu, C., Chen, L., Qin, J., & Wang, P. (2024). A prospective study to compare the diagnostic accuracy of 99mTc-CNDG SPECT/CT and contrast-enhanced CT in staging of non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05953-6
Vancouver
Wang Q, Deng Z, Lu C, Chen L, Qin J, Wang P. A prospective study to compare the diagnostic accuracy of 99mTc-CNDG SPECT/CT and contrast-enhanced CT in staging of non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05953-6
BibTeX
@article{Wang2024,
author = {Wang, Qinfen and Deng, Zhensheng and Lu, Chuangang and Chen, Lijun and Qin, Jiangjun and Wang, Ping},
title = {A prospective study to compare the diagnostic accuracy of 99mTc-CNDG SPECT/CT and contrast-enhanced CT in staging of non-small cell lung cancer},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05953-6}
}
EUVIMED